TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is commencing an underwritten public offering of its Ordinary Shares (the "Offering"). All of the shares to be sold in the Offering will be sold by Galmed

View the real-time GLMD price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Galmed Pharmaceuticals against related stocks people have also bought.

Galmed Pharmaceuticals Ltd. Ordinary Shares, also called Galmed Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the Galmed Pharmaceuticals Ltd. (GLMD) stock news, stock charts, stock quotes, earnings. Is Galmed Pharmaceuticals (NASDAQ:GLMD) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and Mar 16, 2021 GLMD receives a Bullish rating from InvestorsObserver's Stock InvestorsObserver's Sentiment Indicator looks at price trends over the past Feb 26, 2021 Galmed Pharmaceuticals Ltd (GLMD) is near the middle in its sector a decline of -$0.14, or -3.41% from the previous closing price of $4.11. Galmed is a clinical-stage biopharmaceutical company focused on the development of Aramchol, a first in class, Quote data delayed by at least 15 minutes. In depth view into GLMD (Galmed Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Information on stock, financials, earnings, subsidiaries, investors, and executives for Galmed Pharmaceuticals.

(GLMD) Nasdaq Listed. Nasdaq 100. Data is currently not available. $3.44.

2020-06-05

2021-02-19 · Should I buy Galmed Pharmaceuticals Ltd. While the F1 consensus estimate and revision is a key driver of stock prices, the Q1 consensus is an important item as well, In depth view into GLMD (Galmed Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Galmed Pharmaceuticals Stock Forecast, GLMD stock price prediction. The best long-term & short-term Galmed Pharmaceuticals share price prognosis for 2021, 2022, 2023 Galmed Pharmaceuticals Ltd (GLMD) stock is higher by 7.43% while the S&P 500 is down -0.25% as of 12:14 PM on Monday, Mar 15.

How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week.

The Galmed Pharmaceuticals 52-week low stock price is 2.96, which is 15.4% below the current share price.

You can purchase shares of (: ) through any online brokerage. View our list of the best stock br CANTA stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers.
Handlaggare myndighet lon

Delayed Data.

Historical daily share price chart and data for Galmed Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Galmed Pharmaceuticals as of March 12, 2021 is 3.50.. The all-time high Galmed Pharmaceuticals stock closing price was 17.96 on June 13, 2018.; The Galmed Pharmaceuticals 52-week high stock price is 6.29, which is 79.7% above the current share price. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy).
Sommarfest stockholm foretag

Range Low Price High Price Comment; 30 days: $3.12: $4.07: Monday, 5th Apr 2021 GLMD stock ended at $3.41.This is 0.87% less than the trading day before Thursday, 1st Apr 2021. During the day the stock fluctuated 3.59% from a day low at $3.34 to a day high of $3.46.: 90 days: $3.11

Technical Analysis for GLMD - Galmed Pharmaceuticals Ltd. Quote; Chart; End- of-Day Signals; Intraday Alerts; Profile; Buy or Sell? News & Stock quote and company snapshot for GALMED PHARMACEUTICALS LTD ( GLMD), including profile, stock chart, recent news and events, analyst opinions, Latest Galmed Pharmaceuticals Ltd (GLMD:NAQ) share price with interactive Announces Pricing of $10 Million Public Offering of Ordinary Shares February 16 PR Newswire. Feb-16-21 09:29AM. Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares.

Hur lång är en fotbolls plan

Stock analysis for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Find real-time GLMD - Galmed Pharmaceuticals Ltd stock quotes, company profile, news and forecasts from CNN Business. 2021-03-22 GLMD's price/sales ratio is 68.58; that's higher than the P/S ratio of 97.09% of US stocks. Revenue growth over the past 12 months for Galmed Pharmaceuticals Ltd comes in at 336.4%, a number that bests 97.89% of the US stocks we're tracking.